Publicaciones en colaboración con investigadores/as de University of Liège (27)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    BMC Infectious Diseases, Vol. 21, Núm. 1

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  3. SARS-CoV-2 neutralising antibody testing in Europe: Towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

    Eurosurveillance, Vol. 27

2020

  1. Multivariate analysis of dual-point amyloid PET intended to assist the diagnosis of Alzheimer's disease

    Neurocomputing, Vol. 417, pp. 1-9

2019

  1. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911

  2. The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

    Osteoporosis International, Vol. 30, Núm. 1, pp. 71-78

2018

  1. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Energy

    Clinical Nutrition, Vol. 37, Núm. 6, pp. 2309-2314

2012

  1. Documentation of functional and clinical effects of infant nutrition: Setting the scene for COMMENT

    Annals of Nutrition and Metabolism, Vol. 60, Núm. 4, pp. 222-232

  2. Re: ESPGHAN's 2008 recommendation for early introduction of complementary foods: How good is the evidence? (Cattaneo etal. 2011)

    Maternal and Child Nutrition

2011

  1. Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency

    Calcified Tissue International, Vol. 88, Núm. 6, pp. 485-494

1997

  1. Determination rapide par immunodosage de l'hemoglobine glyquee sur sang capillaire comparee a une methode d'affinite pour le boronate et capture d'ions sur sang veineux

    Annales de Biologie Clinique, Vol. 55, Núm. 2, pp. 139-144

1996

  1. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: Methodological aspects and clinical applications

    Diabetes and Metabolism, Vol. 22, Núm. 6, pp. 397-406

1995

  1. AMYLIN ISLET AMYLOID POLYPEPTIDE - BIOCHEMISTRY, PHYSIOLOGY, PATHOPHYSIOLOGY

    DIABETES & METABOLISM, Vol. 21, Núm. 1, pp. 3-25

1994

  1. MAGNESIUM ET DIABETE

    Revue Francaise d'Endocrinologie Clinique - Nutrition et Metabolisme

1989

  1. Lack of deleterious effects of the alpha1-adrenoceptor blocking agent doxazosin on insulin secretion and insulin sensitivity in healthy men

    Current Therapeutic Research - Clinical and Experimental, Vol. 46, Núm. 2, pp. 200-209

  2. Role of insulin and counter-regulatory hormones on the metabolic deterioration that follows insulin withdrawal in diabetic patients

    Revista Espanola de Fisiologia, Vol. 45, Núm. 1, pp. 53-59

1987

  1. The addition of glipizide to insulin therapy in Type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion

    Acta Endocrinologica, Vol. 116, Núm. 3, pp. 364-372